Clinical Trials on Recurrent/Refractory Glioblastoma
Total 9532 results
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Active, not recruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Refractory Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Refractory Glioblastoma | Refractory WHO Grade II Glioma | Refractory WHO Grade III GliomaUnited States
-
Second Affiliated Hospital, School of Medicine,...Huizhou Municipal Central Hospital; BoYuan RunSheng Pharma (Hangzhou) Co.,... and other collaboratorsRecruitingRecurrent Glioblastoma | Refractory GlioblastomaChina
-
Second Affiliated Hospital, School of Medicine,...BoYuan RunSheng Pharma (Hangzhou) Co., Ltd.UnknownRecurrent Glioblastoma | Refractory GlioblastomaChina
-
Arog Pharmaceuticals, Inc.CompletedRecurrent/Refractory GlioblastomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingMalignant Glioma | WHO Grade 3 Glioma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Refractory Primary Central Nervous System Neoplasm | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Brain Neoplasm | Recurrent Childhood...United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); University of California, Los Angeles; Oncoceutics...WithdrawnRecurrent Glioblastoma | Recurrent Gliosarcoma | Recurrent Supratentorial Glioblastoma | Supratentorial GliosarcomaUnited States
-
Massachusetts General HospitalNot yet recruitingGlioblastoma Recurrent, EGFR vIII Mutant | Newly Diagnosed Glioblastoma, EGFRvIII Mutant | Recurrent Glioblastoma, EGFR vIII NegativeUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Refractory GlioblastomaUnited States
-
National Cancer Institute (NCI)SuspendedRecurrent Glioblastoma, IDH-Wildtype | MGMT-Methylated Glioblastoma | Recurrent MGMT-Methylated GlioblastomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Glioblastoma | Giant Cell Glioblastoma | Recurrent GliosarcomaUnited States
-
University of OklahomaGlaxoSmithKlineTerminatedRecurrent Glioblastoma | Recurrent Glioma | Recurrent Astrocytoma | Recurrent OligodendrogliomaUnited States
-
Immatics Biotechnologies GmbHBristol-Myers SquibbRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
Northwestern UniversityBristol-Myers Squibb; Lantheus Medical Imaging; CarTheraRecruitingGlioblastoma | Glioblastoma Multiforme | Gliosarcoma | GBM | Recurrent Glioblastoma | Glioblastoma, IDH-wildtypeUnited States
-
Center for Neurosciences, TucsonGenentech, Inc.CompletedRecurrent Glioblastoma Multiforme | Recurrent GliosarcomaUnited States
-
Jonsson Comprehensive Cancer CenterBristol-Myers Squibb; Northwest Biotherapeutics; Brain Tumor Funders CollaborativeWithdrawnGliosarcoma | Recurrent Glioblastoma | Oligodendroglioma | Small Cell Glioblastoma | Giant Cell GlioblastomaUnited States
-
Boston Scientific CorporationRecruitingGlioblastoma Multiforme | Recurrent GlioblastomaUnited States
-
Sun Yat-sen UniversityUnknown
-
Novartis PharmaceuticalsCompletedRecurrent Glioblastoma MultiformeUnited States, Belgium, Australia, Spain, France, Canada
-
CASI Pharmaceuticals, Inc.CompletedRecurrent Glioblastoma MultiformeUnited States
-
The Second Hospital of Shandong UniversityNot yet recruiting
-
Royan InstituteTehran University of Medical SciencesRecruitingRecurrent Glioblastoma | Glioblastoma MultiformIran, Islamic Republic of
-
WPD Pharmaceuticals Sp. z o.o.National Center for Research and Development, Poland; Worldwide Clinical TrialsRecruitingRecurrent Glioblastoma MultiformePoland
-
Immatics Biotechnologies GmbHRecruitingCancer | Solid Tumor, Adult | Refractory Cancer | Recurrent CancerGermany
-
UNICANCERBristol-Myers SquibbCompletedRecurrent and/or Metastatic Platinum-refractory SCCHNFrance
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Newly Diagnosed Glioblastoma | Recurrent Gliosarcoma | Recurrent Astrocytoma, Grade IV | Newly Diagnosed Gliosarcoma | Newly Diagnosed Astrocytoma, Grade IVUnited States
-
University of AlbertaRecruitingRecurrent Glioblastoma | Glioblastoma - CategoryCanada
-
Prof. Franciszek Lukaszczyk Memorial Oncology CenterNovoCure GmbHActive, not recruitingGlioblastoma Multiforme | Recurrent GlioblastomaPoland
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingGlioblastoma | Malignant Glioma | WHO Grade III Glioma | Recurrent Glioma | Refractory GliomaUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Glioblastoma | Recurrent GliosarcomaUnited States
-
Xoft, Inc.Icad, Inc.TerminatedGlioblastoma | GBM | Recurrent Glioblastoma | Recurrent GBMUnited States
-
Emory UniversityNational Cancer Institute (NCI)WithdrawnRecurrent Glioblastoma | Recurrent Gliosarcoma
-
Gary Archer Ph.D.National Cancer Institute (NCI); Duke Cancer InstituteTerminatedRecurrent Glioblastoma | Recurrent GliosarcomaUnited States
-
Jasper GerritsenMassachusetts General Hospital; Universitaire Ziekenhuizen KU Leuven; University... and other collaboratorsRecruitingGlioblastoma | Glioblastoma Multiforme | Recurrent Glioblastoma | Glioblastoma, IDH-wildtype | Glioblastoma Multiforme, Adult | Glioblastoma Multiforme of Brain | Astrocytoma of Brain | Astrocytoma, MalignantUnited States, Germany, Netherlands, Switzerland, Belgium
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingGlioblastoma | Recurrent Glioblastoma | Recurrent DiseaseCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Glioblastoma | Recurrent GliosarcomaUnited States
-
Accendatech USA Inc.Avance Clinical Pty Ltd.; C3 Research AssociatesRecruitingRecurrent Glioblastoma Multiforme(GBM)United States
-
NovartisTerminatedRecurrent Glioblastoma Multiforme (GBM)United States
-
MediciNovaActive, not recruitingGlioblastoma | GBM | Recurrent Glioblastoma | Newly Diagnosed GlioblastomaUnited States
-
University Hospital FreiburgUniversity of Freiburg; Clinical Trials Center Freiburg; AG-NUK-RTUnknownRecurrent Glioma (Glioblastoma Multiforme)Germany
-
St. Jude Children's Research HospitalNovartis PharmaceuticalsCompletedRecurrent or Refractory Solid Tumors | CNS MalignanciesUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II GliomaUnited States
-
Marcela V. Maus, M.D.,Ph.D.RecruitingGlioblastoma | Malignant Glioma | Recurrent Glioblastoma | Recurrent GliomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Not yet recruitingRecurrent Glioblastoma | Recurrent WHO Grade 4 GliomaUnited States
-
Beijing Sanbo Brain HospitalRecruitingStudy of Recombinant Human Endostatin Combined With Temozolomide and Irinotecan in Recurrent GliomasGlioblastoma, Recurrent | Lower Grade Glioma, RecurrentChina
-
Peregrine PharmaceuticalsCompletedRecurrent Glioblastoma MultiformeUnited States
-
Shayan Moosa, MDRecruitingGlioblastoma Multiforme | GBM | Recurrent GlioblastomaUnited States
-
Istari Oncology, Inc.Active, not recruitingGlioblastoma | Brain Tumor | Recurrent Glioblastoma | Supratentorial GlioblastomaUnited States
-
Duke UniversityBayer; Schering-PloughCompletedRecurrent Glioblastoma MultiformeUnited States
-
Dawonmedax Co., Ltd.RecruitingRecurrent Glioblastoma | Recurrent High-grade Glioma | Recurrent Anaplastic Astrocytoma | Recurrent Anaplastic OligodendrogliomaKorea, Republic of
-
M.D. Anderson Cancer CenterDNAtrix, Inc.RecruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Recurrent Gliosarcoma | Recurrent Anaplastic Astrocytoma | IDH1 wt AlleleUnited States